SlideShare a Scribd company logo
1 of 1
Download to read offline
Exploring the Effects of a High-Fat Diet and Gut Microbiomes on RIP140
Knockdown Mice Resistant to Diet-Induced Type II Diabetes	
Jacob Jensen, Yi-Wei Lin, Li-Na Wei
Department of Pharmacology, University of Minnesota Medical School, University of Minnesota
Introduction and Background
Figure 1:
Metabolic diseases, such as obesity and diet-induced type II diabetes, are a prevalent concern in
Western society. These diseases are primarily linked to a high fat diet, which is composed of trans
and saturated fats, high fructose corn syrup, and carbohydrates1. Unfortunately, because of the high
glucose conditions associated with diet-induced type II diabetes, the inflammation of the arterial
walls is accelerated2. Typically, the recruitment and activation of adipose tissue macrophages (ATM)
play a crucial role in obesity-induced inflammation and insulin resistance. In addition, gut microbiota
may play a significant role in metabolic disorders. Changing the gut microbiota could lead to the
elimination of metabolic syndrome3.
This study explored the effects of feeding macrophage-specific RIP140 knockdown mice
(MφRIP140KD) a high-fat diet and different types of mice feces. Typically, wild type mice are more
prone to diet-induced diabetes while MφRIP140KD show less severe symptoms4.
Figure 1:
(A) Oil red O staining of aortic sinus (left panel) and quantitative
relative lesion size (middle panel) after 16 weeks of western diet
feeding. Average lesion size of ApoE null mice was set as 1. Relative
macrophagic RIP140 mRNA expression level is shown on the right
panel. (B) en face oil red O staining of aorta and quantification. 
Hypothesis
1.  A high-fat diet will increase the expression of RIP140, ATM, inflammation, and insulin
resistance.
2.  When wild type mice are fed the feces of knockdown mice, their gut microbiota’s will alter,
making them less susceptible to diet induced diabetes.
3.  When knockdown mice are fed the feces of wild type mice, their gut microbiota’s will alter,
making them more susceptible to diet induced diabetes4.
Materials and Methods
Results 1 Results 3
Conclusion
•  C57/BL6 mice were used as wild type and MφRIP140KD transgenic mice were generated
•  Experimentations commenced on 8 week old mice
•  Mice from hypothesis one were fed diets for 12 weeks. Mice from hypotheses two and three were
fed diets for 7 weeks. Afterwards, they were fed their own feces for 7 weeks
•  Normal diet contained 18% calories from diet and no detectable amounts of cholesterol. High fat
diet contained 60% calories from fat and 345 mg cholesterol/mg
•  Glucose tolerance test (GTT) and insulin tolerance test (ITT) were performed every three weeks
after over night fasting
•  Oxygen consumption (vO2) was measured via indirect calorimetry for 2 days
•  Fluorescein isothiocyanate labeled dextran was used to measure the intestine’s permeability
•  Mice were euthanized to collect adipose tissue. All mice were euthanized by exposure to a legal
dosage of CO2
•  Adipose tissue was fixed in frozen liquid nitrogen for protein and mRNA analysis. Macrophage
harvested from collected tissues was plated at 1x107 cells/plate in the reagent DMEM for 8 days
•  Following 8 days, a western blot of the cultured adipose tissue was performed
	
	
	
	
	
Figure 2:
•  Microbiome profiles of Wild Type (WT) and MφRIP140KD
animals under Normal Diet and High-Fat Diet conditions
•  Diet and RIP140 expression in mice change gut microbiome
profiles
Results 2
	
	
	
	
	
	
	
	
	
	
	
0
0.5
1
1.5
2
2.5
3
0 0.5 1 1.5 2
WT/WT
WT/KD
KD/WT
KD/KD
Bloodglucose
(foldofinitiallevel)
0.6
0.7
0.8
0.9
1
1.1
1.2
0 0.5 1 1.5 2
WT/WT
WT/KD
KD/WT
KD/KD
Bloodglucose
(foldofinitiallevel)
Figure 3:
•  (A) Glucose tolerance test of WT and KD mice after microbiome
transportation and 8 weeks of high-fat diet feeding
•  (B) Insulin tolerance test of WT and KD mice after microbiome
transportation and 8 weeks of high-fat diet feeding
•  Microbiome transplantation from MφRIP140KD mice improves
diet-induced insulin resistance
A
0
0.5
1
1.5
2
2.5
3
0 1 2
WT/WT
WT/KD
KD/WT
KD/KD
Fitc-dextran(ug/mL)
•  Intestinal permeability analysis of mice after microbiome
transplantation after 8 weeks of high-fat diet feeding. WT/WT: WT
as donors and WT as recipients, WT/KD: WT as donors and KD as
recipients, KD/WT: KD as donors and WT as recipients, KD/KD:
KD as donors and KD as recipients.
•  Microbiome transplantations can possibly create affordable clinical
treatments for obesity and diet induced type II diabetes
•  RIP140 expression alters gut microbiome in mice fed with a normal or high-fat diet
•  Microbiome transplantation from MφRIP140KD mice to WT mice prevents diet-
induced metabolic disorders
•  Microbiome transplantations can lead to creating affordable clinical treatments for
obesity and diet-induced type II diabetes
References
1)  Hu, F. B. Globalization of Diabetes The role of diet, lifestyle, and genes. Diabetes
Care 34, 1249-1257 (2011).
2)  Chait, A. & Bornfeldt, K. E. Diabetes and atherosclerosis: is there a role for
hyperglycemia? J. Lipid Res. 50, S335-S339 (2009).
3)  Liu, P.-S. et al. Reducing RIP140 expression in macophage alters ATM infiltration,
facilitates white adipose tissue browning, and prevents high-fat diet-induced insulin
resistance. Diabetes 63, 4021-4031 (2014).
4)  Ho, P.-C., Tsui, Y.-C., Feng, X., Greaves, D. R. & Wei, L.-N. NF-κB-mediated
degradation of the coactivator RIP140 regulates inflammatory responses and
contributes to endotoxin tolerance. Nat. Immunol. 13, 379–386 (2012)
B
Funding
•  Sponsored by the Undergraduate Research Opportunities Project
A B

More Related Content

What's hot

‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...
‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...
‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...Norwich Research Park
 
Inaugural lecture Norwich UEA 14 oct 2014
Inaugural lecture Norwich UEA 14 oct 2014Inaugural lecture Norwich UEA 14 oct 2014
Inaugural lecture Norwich UEA 14 oct 2014Norwich Research Park
 
Diet Dominates Host Genotype in Shaping the Murine Gut Microbiota
Diet Dominates Host Genotype in Shaping the Murine Gut MicrobiotaDiet Dominates Host Genotype in Shaping the Murine Gut Microbiota
Diet Dominates Host Genotype in Shaping the Murine Gut MicrobiotaAlireza Kashani
 
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...IFSMED
 
Diet, Microbiota and Metabolic Health by Renée Wilson
Diet, Microbiota and Metabolic Health by Renée WilsonDiet, Microbiota and Metabolic Health by Renée Wilson
Diet, Microbiota and Metabolic Health by Renée WilsonKiwifruit Symposium
 
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...Norwich Research Park
 
From  Nutrigenomics to Systems Nutrition - The role of nutrition in metabolic...
From  Nutrigenomics to Systems Nutrition - The role of nutrition in metabolic...From  Nutrigenomics to Systems Nutrition - The role of nutrition in metabolic...
From  Nutrigenomics to Systems Nutrition - The role of nutrition in metabolic...Norwich Research Park
 
The influence of intestinal microflora in development of diabetes type II
The influence of intestinal microflora in development of diabetes type IIThe influence of intestinal microflora in development of diabetes type II
The influence of intestinal microflora in development of diabetes type IIIvan Mindov
 
Gut flora in diabetes
Gut flora in diabetesGut flora in diabetes
Gut flora in diabetesNadia Shams
 
Hyperlipidemia & Diabetes & Gut Microbiota
Hyperlipidemia & Diabetes & Gut Microbiota Hyperlipidemia & Diabetes & Gut Microbiota
Hyperlipidemia & Diabetes & Gut Microbiota Seyed Davar Siadat
 
Gasbarrini A. Microbiota, Antibiotici e Probiotici in Gastroenterologia. ASMa...
Gasbarrini A. Microbiota, Antibiotici e Probiotici in Gastroenterologia. ASMa...Gasbarrini A. Microbiota, Antibiotici e Probiotici in Gastroenterologia. ASMa...
Gasbarrini A. Microbiota, Antibiotici e Probiotici in Gastroenterologia. ASMa...Gianfranco Tammaro
 
Personalised nutrition for the gut microbiome
Personalised nutrition for the gut microbiomePersonalised nutrition for the gut microbiome
Personalised nutrition for the gut microbiomeEFSA EU
 
Kiwifruit – A Double Agent for Glycaemic Control and Nutrient Enhancement by...
Kiwifruit – A Double Agent for Glycaemic Control and Nutrient Enhancement  by...Kiwifruit – A Double Agent for Glycaemic Control and Nutrient Enhancement  by...
Kiwifruit – A Double Agent for Glycaemic Control and Nutrient Enhancement by...Kiwifruit Symposium
 
Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...
Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...
Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...UC San Diego AntiViral Research Center
 
Microbiome and obesity
Microbiome and obesity Microbiome and obesity
Microbiome and obesity Erin Davis
 
Gut microbiota in health and disease
Gut microbiota in health and disease Gut microbiota in health and disease
Gut microbiota in health and disease Asma AlQahtani
 
Seminar_JB_Presesntation
Seminar_JB_PresesntationSeminar_JB_Presesntation
Seminar_JB_PresesntationJuan Barrera
 

What's hot (20)

‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...
‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...
‘From Molecular to Systems Nutrition. Lessons from mouse to man’ NUGO Dublin...
 
Nutrigenomics of FAT
Nutrigenomics of FAT Nutrigenomics of FAT
Nutrigenomics of FAT
 
Inaugural lecture Norwich UEA 14 oct 2014
Inaugural lecture Norwich UEA 14 oct 2014Inaugural lecture Norwich UEA 14 oct 2014
Inaugural lecture Norwich UEA 14 oct 2014
 
Diet Dominates Host Genotype in Shaping the Murine Gut Microbiota
Diet Dominates Host Genotype in Shaping the Murine Gut MicrobiotaDiet Dominates Host Genotype in Shaping the Murine Gut Microbiota
Diet Dominates Host Genotype in Shaping the Murine Gut Microbiota
 
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...
Ankylosing Spondylitis the gut and the bugs: an integrative approach to treat...
 
Diet, Microbiota and Metabolic Health by Renée Wilson
Diet, Microbiota and Metabolic Health by Renée WilsonDiet, Microbiota and Metabolic Health by Renée Wilson
Diet, Microbiota and Metabolic Health by Renée Wilson
 
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
Nanjing 2 2013 Lecture "Nutrigenomics part 2" From healthy to too much: The r...
 
Yuan kun lee
Yuan kun leeYuan kun lee
Yuan kun lee
 
From  Nutrigenomics to Systems Nutrition - The role of nutrition in metabolic...
From  Nutrigenomics to Systems Nutrition - The role of nutrition in metabolic...From  Nutrigenomics to Systems Nutrition - The role of nutrition in metabolic...
From  Nutrigenomics to Systems Nutrition - The role of nutrition in metabolic...
 
The influence of intestinal microflora in development of diabetes type II
The influence of intestinal microflora in development of diabetes type IIThe influence of intestinal microflora in development of diabetes type II
The influence of intestinal microflora in development of diabetes type II
 
Gut flora in diabetes
Gut flora in diabetesGut flora in diabetes
Gut flora in diabetes
 
Hyperlipidemia & Diabetes & Gut Microbiota
Hyperlipidemia & Diabetes & Gut Microbiota Hyperlipidemia & Diabetes & Gut Microbiota
Hyperlipidemia & Diabetes & Gut Microbiota
 
Gasbarrini A. Microbiota, Antibiotici e Probiotici in Gastroenterologia. ASMa...
Gasbarrini A. Microbiota, Antibiotici e Probiotici in Gastroenterologia. ASMa...Gasbarrini A. Microbiota, Antibiotici e Probiotici in Gastroenterologia. ASMa...
Gasbarrini A. Microbiota, Antibiotici e Probiotici in Gastroenterologia. ASMa...
 
Personalised nutrition for the gut microbiome
Personalised nutrition for the gut microbiomePersonalised nutrition for the gut microbiome
Personalised nutrition for the gut microbiome
 
Kiwifruit – A Double Agent for Glycaemic Control and Nutrient Enhancement by...
Kiwifruit – A Double Agent for Glycaemic Control and Nutrient Enhancement  by...Kiwifruit – A Double Agent for Glycaemic Control and Nutrient Enhancement  by...
Kiwifruit – A Double Agent for Glycaemic Control and Nutrient Enhancement by...
 
The role of the gut microbiota in nutrition and health
The role of the gut microbiota in nutrition and healthThe role of the gut microbiota in nutrition and health
The role of the gut microbiota in nutrition and health
 
Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...
Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...
Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...
 
Microbiome and obesity
Microbiome and obesity Microbiome and obesity
Microbiome and obesity
 
Gut microbiota in health and disease
Gut microbiota in health and disease Gut microbiota in health and disease
Gut microbiota in health and disease
 
Seminar_JB_Presesntation
Seminar_JB_PresesntationSeminar_JB_Presesntation
Seminar_JB_Presesntation
 

Viewers also liked

Exploring the Effects of Gut Microbiomes on RIP140 Knockdown Mice Resistant t...
Exploring the Effects of Gut Microbiomes on RIP140 Knockdown Mice Resistant t...Exploring the Effects of Gut Microbiomes on RIP140 Knockdown Mice Resistant t...
Exploring the Effects of Gut Microbiomes on RIP140 Knockdown Mice Resistant t...Jacob Jensen
 
Pharmacogenomic Clinical Studies
Pharmacogenomic Clinical StudiesPharmacogenomic Clinical Studies
Pharmacogenomic Clinical StudiesRyan Squire
 
2007aquilante-persmed
2007aquilante-persmed2007aquilante-persmed
2007aquilante-persmedpharmdude
 
Knockdown of lncRNAs: exploring RNAi and antisense oligo methods
Knockdown of lncRNAs: exploring RNAi and antisense oligo methodsKnockdown of lncRNAs: exploring RNAi and antisense oligo methods
Knockdown of lncRNAs: exploring RNAi and antisense oligo methodsIntegrated DNA Technologies
 

Viewers also liked (8)

Exploring the Effects of Gut Microbiomes on RIP140 Knockdown Mice Resistant t...
Exploring the Effects of Gut Microbiomes on RIP140 Knockdown Mice Resistant t...Exploring the Effects of Gut Microbiomes on RIP140 Knockdown Mice Resistant t...
Exploring the Effects of Gut Microbiomes on RIP140 Knockdown Mice Resistant t...
 
BIOL3200 PROPOSAL
BIOL3200 PROPOSALBIOL3200 PROPOSAL
BIOL3200 PROPOSAL
 
LTPPoster
LTPPosterLTPPoster
LTPPoster
 
Pharmacogenomic Clinical Studies
Pharmacogenomic Clinical StudiesPharmacogenomic Clinical Studies
Pharmacogenomic Clinical Studies
 
2007aquilante-persmed
2007aquilante-persmed2007aquilante-persmed
2007aquilante-persmed
 
Knockdown of lncRNAs: exploring RNAi and antisense oligo methods
Knockdown of lncRNAs: exploring RNAi and antisense oligo methodsKnockdown of lncRNAs: exploring RNAi and antisense oligo methods
Knockdown of lncRNAs: exploring RNAi and antisense oligo methods
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 
Pharmacogenomics
PharmacogenomicsPharmacogenomics
Pharmacogenomics
 

Similar to UROP Poster Jacob Jensen

screening methodes of anti-diabetic drugs
screening methodes of anti-diabetic drugsscreening methodes of anti-diabetic drugs
screening methodes of anti-diabetic drugsborude123
 
Preclinical screening of anti diabetic drugs
Preclinical screening of anti diabetic drugsPreclinical screening of anti diabetic drugs
Preclinical screening of anti diabetic drugsAbu Sufiyan Chhipa
 
PRECLINICAL SCREENING OF ANTIDIABETICS.pptx
PRECLINICAL SCREENING OF  ANTIDIABETICS.pptxPRECLINICAL SCREENING OF  ANTIDIABETICS.pptx
PRECLINICAL SCREENING OF ANTIDIABETICS.pptxVincyDinakaran
 
Firoz ahmad m.sc.bio chemistry ppt daibetic nephropathy copy
Firoz ahmad m.sc.bio chemistry ppt  daibetic nephropathy   copyFiroz ahmad m.sc.bio chemistry ppt  daibetic nephropathy   copy
Firoz ahmad m.sc.bio chemistry ppt daibetic nephropathy copyFirozAhmad30
 
Experimental evaluation of anti-diabetics
Experimental evaluation of anti-diabeticsExperimental evaluation of anti-diabetics
Experimental evaluation of anti-diabeticsKirtan Bhatt
 
Dana Foundation 2010
Dana Foundation 2010Dana Foundation 2010
Dana Foundation 2010JesseAitken
 
In- vitro and in-vivo screening of Hypoglycemics.
In- vitro and in-vivo screening of Hypoglycemics.In- vitro and in-vivo screening of Hypoglycemics.
In- vitro and in-vivo screening of Hypoglycemics.Student
 
preclinical screening methods for Antidiabetic drugs
 preclinical screening methods for Antidiabetic drugs preclinical screening methods for Antidiabetic drugs
preclinical screening methods for Antidiabetic drugsSachinGulia12
 
Gut microbiomes as pharmacological target
Gut microbiomes as pharmacological targetGut microbiomes as pharmacological target
Gut microbiomes as pharmacological targetAdeel Zafar
 
ANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGS
ANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGSANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGS
ANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGSGOPALASATHEESKUMAR K
 
Diet-Induced Metabolic Syndrome models.pdf
Diet-Induced Metabolic Syndrome models.pdfDiet-Induced Metabolic Syndrome models.pdf
Diet-Induced Metabolic Syndrome models.pdfAgustin Carmona Castro
 
محاضرة التغذية الثانيه
محاضرة التغذية الثانيهمحاضرة التغذية الثانيه
محاضرة التغذية الثانيهAnwar Al-thomali
 
Anti obesity screening models
Anti obesity screening modelsAnti obesity screening models
Anti obesity screening modelsAshfaq9697931281
 
Models for screening of antidiabetic agents
Models for screening of antidiabetic agentsModels for screening of antidiabetic agents
Models for screening of antidiabetic agentsTabindah Hesam
 
Introduction to diabetes and anti diabetic drug screening models
Introduction to diabetes and anti diabetic drug screening modelsIntroduction to diabetes and anti diabetic drug screening models
Introduction to diabetes and anti diabetic drug screening modelsvaishali chaddha
 
Transgenic animal (pharmacology) (M.PHARM)
Transgenic animal (pharmacology) (M.PHARM)Transgenic animal (pharmacology) (M.PHARM)
Transgenic animal (pharmacology) (M.PHARM)Baidehi Mitra
 
Screening Models for Anti-Diabetic Drugs.
Screening Models for Anti-Diabetic Drugs.Screening Models for Anti-Diabetic Drugs.
Screening Models for Anti-Diabetic Drugs.Nisar Ali
 
The association between gut microbiota and body weight
The association between gut microbiota and body weightThe association between gut microbiota and body weight
The association between gut microbiota and body weightAshwath Venkatasubramanian
 

Similar to UROP Poster Jacob Jensen (20)

screening methodes of anti-diabetic drugs
screening methodes of anti-diabetic drugsscreening methodes of anti-diabetic drugs
screening methodes of anti-diabetic drugs
 
Diabetes & microbiota
Diabetes & microbiotaDiabetes & microbiota
Diabetes & microbiota
 
Preclinical screening of anti diabetic drugs
Preclinical screening of anti diabetic drugsPreclinical screening of anti diabetic drugs
Preclinical screening of anti diabetic drugs
 
PRECLINICAL SCREENING OF ANTIDIABETICS.pptx
PRECLINICAL SCREENING OF  ANTIDIABETICS.pptxPRECLINICAL SCREENING OF  ANTIDIABETICS.pptx
PRECLINICAL SCREENING OF ANTIDIABETICS.pptx
 
Firoz ahmad m.sc.bio chemistry ppt daibetic nephropathy copy
Firoz ahmad m.sc.bio chemistry ppt  daibetic nephropathy   copyFiroz ahmad m.sc.bio chemistry ppt  daibetic nephropathy   copy
Firoz ahmad m.sc.bio chemistry ppt daibetic nephropathy copy
 
Experimental evaluation of anti-diabetics
Experimental evaluation of anti-diabeticsExperimental evaluation of anti-diabetics
Experimental evaluation of anti-diabetics
 
Dana Foundation 2010
Dana Foundation 2010Dana Foundation 2010
Dana Foundation 2010
 
In- vitro and in-vivo screening of Hypoglycemics.
In- vitro and in-vivo screening of Hypoglycemics.In- vitro and in-vivo screening of Hypoglycemics.
In- vitro and in-vivo screening of Hypoglycemics.
 
preclinical screening methods for Antidiabetic drugs
 preclinical screening methods for Antidiabetic drugs preclinical screening methods for Antidiabetic drugs
preclinical screening methods for Antidiabetic drugs
 
Gut microbiomes as pharmacological target
Gut microbiomes as pharmacological targetGut microbiomes as pharmacological target
Gut microbiomes as pharmacological target
 
ANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGS
ANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGSANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGS
ANIMAL MODELS FOR BIOLOGICAL SCREENING OF ANTI-DIABETIC DRUGS
 
Diet-Induced Metabolic Syndrome models.pdf
Diet-Induced Metabolic Syndrome models.pdfDiet-Induced Metabolic Syndrome models.pdf
Diet-Induced Metabolic Syndrome models.pdf
 
محاضرة التغذية الثانيه
محاضرة التغذية الثانيهمحاضرة التغذية الثانيه
محاضرة التغذية الثانيه
 
Anti obesity screening models
Anti obesity screening modelsAnti obesity screening models
Anti obesity screening models
 
nutrition.pptx
nutrition.pptxnutrition.pptx
nutrition.pptx
 
Models for screening of antidiabetic agents
Models for screening of antidiabetic agentsModels for screening of antidiabetic agents
Models for screening of antidiabetic agents
 
Introduction to diabetes and anti diabetic drug screening models
Introduction to diabetes and anti diabetic drug screening modelsIntroduction to diabetes and anti diabetic drug screening models
Introduction to diabetes and anti diabetic drug screening models
 
Transgenic animal (pharmacology) (M.PHARM)
Transgenic animal (pharmacology) (M.PHARM)Transgenic animal (pharmacology) (M.PHARM)
Transgenic animal (pharmacology) (M.PHARM)
 
Screening Models for Anti-Diabetic Drugs.
Screening Models for Anti-Diabetic Drugs.Screening Models for Anti-Diabetic Drugs.
Screening Models for Anti-Diabetic Drugs.
 
The association between gut microbiota and body weight
The association between gut microbiota and body weightThe association between gut microbiota and body weight
The association between gut microbiota and body weight
 

UROP Poster Jacob Jensen

  • 1. Exploring the Effects of a High-Fat Diet and Gut Microbiomes on RIP140 Knockdown Mice Resistant to Diet-Induced Type II Diabetes Jacob Jensen, Yi-Wei Lin, Li-Na Wei Department of Pharmacology, University of Minnesota Medical School, University of Minnesota Introduction and Background Figure 1: Metabolic diseases, such as obesity and diet-induced type II diabetes, are a prevalent concern in Western society. These diseases are primarily linked to a high fat diet, which is composed of trans and saturated fats, high fructose corn syrup, and carbohydrates1. Unfortunately, because of the high glucose conditions associated with diet-induced type II diabetes, the inflammation of the arterial walls is accelerated2. Typically, the recruitment and activation of adipose tissue macrophages (ATM) play a crucial role in obesity-induced inflammation and insulin resistance. In addition, gut microbiota may play a significant role in metabolic disorders. Changing the gut microbiota could lead to the elimination of metabolic syndrome3. This study explored the effects of feeding macrophage-specific RIP140 knockdown mice (MφRIP140KD) a high-fat diet and different types of mice feces. Typically, wild type mice are more prone to diet-induced diabetes while MφRIP140KD show less severe symptoms4. Figure 1: (A) Oil red O staining of aortic sinus (left panel) and quantitative relative lesion size (middle panel) after 16 weeks of western diet feeding. Average lesion size of ApoE null mice was set as 1. Relative macrophagic RIP140 mRNA expression level is shown on the right panel. (B) en face oil red O staining of aorta and quantification. Hypothesis 1.  A high-fat diet will increase the expression of RIP140, ATM, inflammation, and insulin resistance. 2.  When wild type mice are fed the feces of knockdown mice, their gut microbiota’s will alter, making them less susceptible to diet induced diabetes. 3.  When knockdown mice are fed the feces of wild type mice, their gut microbiota’s will alter, making them more susceptible to diet induced diabetes4. Materials and Methods Results 1 Results 3 Conclusion •  C57/BL6 mice were used as wild type and MφRIP140KD transgenic mice were generated •  Experimentations commenced on 8 week old mice •  Mice from hypothesis one were fed diets for 12 weeks. Mice from hypotheses two and three were fed diets for 7 weeks. Afterwards, they were fed their own feces for 7 weeks •  Normal diet contained 18% calories from diet and no detectable amounts of cholesterol. High fat diet contained 60% calories from fat and 345 mg cholesterol/mg •  Glucose tolerance test (GTT) and insulin tolerance test (ITT) were performed every three weeks after over night fasting •  Oxygen consumption (vO2) was measured via indirect calorimetry for 2 days •  Fluorescein isothiocyanate labeled dextran was used to measure the intestine’s permeability •  Mice were euthanized to collect adipose tissue. All mice were euthanized by exposure to a legal dosage of CO2 •  Adipose tissue was fixed in frozen liquid nitrogen for protein and mRNA analysis. Macrophage harvested from collected tissues was plated at 1x107 cells/plate in the reagent DMEM for 8 days •  Following 8 days, a western blot of the cultured adipose tissue was performed Figure 2: •  Microbiome profiles of Wild Type (WT) and MφRIP140KD animals under Normal Diet and High-Fat Diet conditions •  Diet and RIP140 expression in mice change gut microbiome profiles Results 2 0 0.5 1 1.5 2 2.5 3 0 0.5 1 1.5 2 WT/WT WT/KD KD/WT KD/KD Bloodglucose (foldofinitiallevel) 0.6 0.7 0.8 0.9 1 1.1 1.2 0 0.5 1 1.5 2 WT/WT WT/KD KD/WT KD/KD Bloodglucose (foldofinitiallevel) Figure 3: •  (A) Glucose tolerance test of WT and KD mice after microbiome transportation and 8 weeks of high-fat diet feeding •  (B) Insulin tolerance test of WT and KD mice after microbiome transportation and 8 weeks of high-fat diet feeding •  Microbiome transplantation from MφRIP140KD mice improves diet-induced insulin resistance A 0 0.5 1 1.5 2 2.5 3 0 1 2 WT/WT WT/KD KD/WT KD/KD Fitc-dextran(ug/mL) •  Intestinal permeability analysis of mice after microbiome transplantation after 8 weeks of high-fat diet feeding. WT/WT: WT as donors and WT as recipients, WT/KD: WT as donors and KD as recipients, KD/WT: KD as donors and WT as recipients, KD/KD: KD as donors and KD as recipients. •  Microbiome transplantations can possibly create affordable clinical treatments for obesity and diet induced type II diabetes •  RIP140 expression alters gut microbiome in mice fed with a normal or high-fat diet •  Microbiome transplantation from MφRIP140KD mice to WT mice prevents diet- induced metabolic disorders •  Microbiome transplantations can lead to creating affordable clinical treatments for obesity and diet-induced type II diabetes References 1)  Hu, F. B. Globalization of Diabetes The role of diet, lifestyle, and genes. Diabetes Care 34, 1249-1257 (2011). 2)  Chait, A. & Bornfeldt, K. E. Diabetes and atherosclerosis: is there a role for hyperglycemia? J. Lipid Res. 50, S335-S339 (2009). 3)  Liu, P.-S. et al. Reducing RIP140 expression in macophage alters ATM infiltration, facilitates white adipose tissue browning, and prevents high-fat diet-induced insulin resistance. Diabetes 63, 4021-4031 (2014). 4)  Ho, P.-C., Tsui, Y.-C., Feng, X., Greaves, D. R. & Wei, L.-N. NF-κB-mediated degradation of the coactivator RIP140 regulates inflammatory responses and contributes to endotoxin tolerance. Nat. Immunol. 13, 379–386 (2012) B Funding •  Sponsored by the Undergraduate Research Opportunities Project A B